Literature DB >> 33687676

Ex Vivo Model of Spontaneous Neuroretinal Degeneration for Evaluating Stem Cells' Paracrine Properties.

Ivan Fernandez-Bueno1,2,3, Ricardo Usategui-Martin4.   

Abstract

Ex vivo neuroretina cultures closely resemble in vivo conditions, retaining the complex neuroretina cells dynamics, connections, and functionality, under controlled conditions. Therefore, these models have allowed advancing in the knowledge of retinal physiology and pathobiology over the years. Furthermore, the ex vivo neuroretina models represent an adequate tool for evaluating stem cell therapies over neuroretinal degeneration processes.Here, we describe a physically separated co-culture of neuroretina explants with stem cells to evaluate the effect of stem cells paracrine properties on spontaneous neuroretinal degeneration.

Entities:  

Keywords:  Advanced therapies; Cell therapy; Ex vivo neuroretina; Neuroprotection; Neuroretina; Paracrine properties; Retinal degeneration; Stem cells

Mesh:

Year:  2021        PMID: 33687676     DOI: 10.1007/978-1-0716-1225-5_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  46 in total

1.  Organ-culture analysis of inherited retinal degeneration in rodents.

Authors:  R L SIDMAN
Journal:  Natl Cancer Inst Monogr       Date:  1963-03

2.  Inherited retinal dystrophy in the mouse: its appearance in eyes and retinae cultured in vitro.

Authors:  D R LUCAS
Journal:  J Embryol Exp Morphol       Date:  1958-12

3.  In vitro culture of the eye and the retina of the mouse and rat.

Authors:  D R LUCAS; O A TROWELL
Journal:  J Embryol Exp Morphol       Date:  1958-03

4.  A modified technique for organ culture in vitro.

Authors:  O A TROWELL
Journal:  Exp Cell Res       Date:  1954-02       Impact factor: 3.905

5.  THE FORMATION OF ROSETTES IN THE RAT RETINA.

Authors:  K Tansley
Journal:  Br J Ophthalmol       Date:  1933-06       Impact factor: 4.638

Review 6.  Current Advancements in the Development and Characterization of Full-Thickness Adult Neuroretina Organotypic Culture Systems.

Authors:  Christina L Rettinger; Heuy-Ching Wang
Journal:  Cells Tissues Organs       Date:  2019-03-15       Impact factor: 2.481

7.  Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures.

Authors:  Sonia Labrador-Velandia; Maria Luz Alonso-Alonso; Salvatore Di Lauro; Maria Teresa García-Gutierrez; Girish K Srivastava; José Carlos Pastor; Ivan Fernandez-Bueno
Journal:  Exp Eye Res       Date:  2019-05-17       Impact factor: 3.467

8.  Human organotypic retinal cultures (HORCs) as a chronic experimental model for investigation of retinal ganglion cell degeneration.

Authors:  Andrew Osborne; Marina Hopes; Phillip Wright; David C Broadway; Julie Sanderson
Journal:  Exp Eye Res       Date:  2015-10-01       Impact factor: 3.467

9.  Time course modifications in organotypic culture of human neuroretina.

Authors:  Iván Fernandez-Bueno; Laura Fernández-Sánchez; Manuel J Gayoso; María T García-Gutierrez; José C Pastor; Nicolás Cuenca
Journal:  Exp Eye Res       Date:  2012-09-26       Impact factor: 3.467

10.  Histotypic differentiation of neonatal mouse retina in organ culture.

Authors:  A R Caffé; H Visser; H G Jansen; S Sanyal
Journal:  Curr Eye Res       Date:  1989-10       Impact factor: 2.424

View more
  2 in total

1.  Programmed Cell Death and Autophagy in an in vitro Model of Spontaneous Neuroretinal Degeneration.

Authors:  Kevin Puertas-Neyra; Nadia Galindo-Cabello; Leticia A Hernández-Rodríguez; Fernando González-Pérez; José Carlos Rodríguez-Cabello; Rogelio González-Sarmiento; José Carlos Pastor; Ricardo Usategui-Martín; Ivan Fernandez-Bueno
Journal:  Front Neuroanat       Date:  2022-02-11       Impact factor: 3.856

2.  Retinal Neuroprotective Effect of Mesenchymal Stem Cells Secretome Through Modulation of Oxidative Stress, Autophagy, and Programmed Cell Death.

Authors:  Ricardo Usategui-Martín; Kevin Puertas-Neyra; Nadia Galindo-Cabello; Leticia A Hernández-Rodríguez; Fernando González-Pérez; José Carlos Rodríguez-Cabello; Rogelio González-Sarmiento; José Carlos Pastor; Ivan Fernandez-Bueno
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-04-01       Impact factor: 4.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.